Floatz logo

15 assets in Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation

Therapeutic assets addressing Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Etoposide
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
Alice MimsP3BBB (75)
Cytarabine
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
The First Affiliated Hospital of Soochow UniversityP3BBB (74)
Idarubicin
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
The First Affiliated Hospital of Soochow UniversityP2BBB (73)
Cyclophosphamide
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
BGI, ChinaP3BBB (72)
Mitoxantrone
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
BGI, ChinaP2BBB (72)
Fludarabine
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
Rutgers, The State University of New JerseyP3BB (71)
Decitabine
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
BGI, ChinaP3BB (70)
Azacitidine
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
The First Affiliated Hospital of Soochow UniversityP2BB (69)
Gemtuzumab Ozogamicin
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
Wake Forest University Health SciencesP2BB (64)
Avapritinib
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
The First Affiliated Hospital of Soochow UniversityP1/2CCC (48)
Filgrastim-Sndz
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
M.D. Anderson Cancer CenterP2CC (46)
Targeted Aml1-Eto Neoantigen Cytotoxic T Cells
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
BGI, ChinaEarly P1C (39)